Julija Beldeninovienė
About
Julija Beldeninovienė is a Specialist Counsel, Attorney-at-Law having over 17 years of experience in IP, IT, Pharmaceutical law and related litigation. She counsels clients through various types of IP-related contract negotiations, including settlement agreements, licenses, IP assignment and other agreements. Her practice also involves pre-litigation strategy and all aspects of litigation and dispute resolution relating to patents, SPCs, trademarks, copyrights, designs, and confidential information. Julija has acted in numerous cases related to IP and unfair competition, including the first pharmaceutical patent invalidation and patent enforcement disputes in Lithuania.
- Intellectual Property – Band 3, Chambers Europe 2025
- Intellectual property – Leading associates, The Legal 500 2025
- Intellectual Property – Star Associate, Chambers 2023
- Intellectual property – Rising star, The Legal 500 2023
- Intellectual Property – Rising star, IP STARS 2022
Languages
- Lithuanian, English, Russian
Membership & education
- Since 2010 Member of the Lithuanian Bar Association
- 2004 Faculty of Law, Vilnius University, Master’s degree in Law
Baltic Disputes Market Overview 2025 (2026 - 02 - 19)
Drug & Medical Device Litigation 2020 Lithuania (2020 - 04 - 29)
Baltic IP & IT Law News – October 2019 (2019 - 10 - 31)
Baltic IP & IT Law News – July 2019 (2019 - 07 - 16)
Enforcement of Intellectual Property Rights in the EU Member States (2019 - 03 - 04)
We are driven by your recognition
You need to load content from reCAPTCHA to submit the form. Please note that doing so will share data with third-party providers.
More InformationYou are currently viewing a placeholder content from Turnstile. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More InformationYou are currently viewing a placeholder content from Facebook. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More InformationYou are currently viewing a placeholder content from Instagram. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More InformationYou are currently viewing a placeholder content from X. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More Information